Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes
Kershaw V. Patel(Houston Methodist), Ambarish Pandey(The University of Texas Southwestern Medical Center), Chiadi E. Ndumele(Johns Hopkins University), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), James A. de Lemos(Universität Hamburg), Christie M. Ballantyne(Baylor College of Medicine), Zainali Chunawala(Southwestern Medical Center), Mark A. Espeland(Wake Forest University), Javed Butler(Saint Luke's Health System), Subodh Verma(St. Michael's Hospital), Thomas J. Wang(Harvard University), Katelyn R Garcia(Wake Forest University), James L. Januzzi(Harvard University), Alain G. Bertoni(Wake Forest University), Carolyn S.P. Lam(National University of Singapore), Matthew W. Segar(Unknown)
Cited by 12
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k